CLOs on the Move

Meadowview Manor Retirement HM

www.meadowviewmanor.com

 
Meadowview Manor Retirement HM is a Mc Veytown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

AdventHealth

AdventHealth is a faith-based health care organization headquartered in Altamonte Springs, Florida. A national leader in quality, safety and patient satisfaction, AdventHealths nearly 77,000 employees maintain a tradition of whole-person health by caring for the physical, emotional and spiritual needs of every patient. With 46 hospital campuses and nearly 8,200 licensed beds in 10 states, AdventHealth facilities incorporate the latest technological advancements and clinical research to serve more than 4.7 million patients annually. The full continuum of integrated care also includes urgent care centers, home health and hospice agencies, and skilled nursing facilities. Each AdventHealth facility operates independently in delivering care and services to best meet the needs of the local communities they serve. While each entity is unique, all remain united in one mission of Extending the Healing Ministry of Christ.

Northwest Florida Blood Ctr

Northwest Florida Blood Ctr is a Pensacola, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Les Restaurants Pacini

Les Restaurants Pacini is a La Prairie, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

JK Associates

JK Associates is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.